Skip to main content
. Author manuscript; available in PMC: 2014 Jul 1.
Published in final edited form as: Arch Biochem Biophys. 2012 Oct 19;535(1):22–29. doi: 10.1016/j.abb.2012.10.005

Fig. 3.

Fig. 3

PKCβII inhibition decreases contractile and relaxation kinetics. Developed tension (A), time to peak tension (B), time from peak tension to 50% relaxation (C), and time from peak tension to 90% relaxation (D) before and after application of PKCβII peptide inhibitor I trifluoroacetate salt, at taut and optimal muscle lengths. Data collected at 1 Hz, 37 °C, n = 24.